Net profit of Norris Medicines reported to Rs 0.17 crore in the quarter ended March 2024 as against net loss of Rs 0.54 crore during the previous quarter ended March 2023. Sales rose 23.14% to Rs 1.49 crore in the quarter ended March 2024 as against Rs 1.21 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 1.19 crore in the year ended March 2024 as against net loss of Rs 1.75 crore during the previous year ended March 2023. Sales declined 32.54% to Rs 5.64 crore in the year ended March 2024 as against Rs 8.36 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1.491.21 23 5.648.36 -33 OPM %32.2146.28 --3.3711.12 - PBDT0.400.20 100 -0.53-0.56 5 PBT0.260.02 1200 -1.10-1.19 8 NP0.17-0.54 LP -1.19-1.75 32 Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 29 May 2024.Powered by Capital Market - Live News

Net Loss of Norris Medicines reported to Rs 0.27 crore in the quarter ended December 2023 as against net loss of Rs 0.20 crore during the previous quarter ended December 2022. Sales declined 79.43% to Rs 0.65 crore in the quarter ended December 2023 as against Rs 3.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.653.16 -79 OPM %-6.1510.76 - PBDT-0.13-0.05 -160 PBT-0.27-0.20 -35 NP-0.27-0.20 -35 Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 February 2024. The meeting would commence at 11.00 am.Powered by Capital Market - Live News

Norris Medicines announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 January 2024 .Powered by Capital Market - Live News